Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Pearce

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1979
Management of thoracic outlet syndromeE C McGough, M B Pearce, J P Byrne
JAMA|September 16, 1992
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) GroupH Buchwald, J P Matts, L L Fitch, et al.
The New England Journal of Medicine|October 4, 1990
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)H Buchwald, R L Varco, J P Matts, et al.
Controlled Clinical Trials|April 11, 1991
Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH GroupJ P Matts, H Buchwald, L L Fitch, et al.
Journal of Clinical Epidemiology|March 1, 1995
Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarctionJ P Matts, H Buchwald, L L Fitch, et al.
Surgery|October 1, 1982
The Program on the Surgical Control of the Hyperlipidemias: a status reportH Buchwald, R B Moore, J P Matts, et al.
Clinical and Vaccine Immunology : CVI|September 8, 2012
Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humansJ E Ledgerwood, Z Hu, I J Gordon, et al.
Archives of Internal Medicine|June 13, 1998
Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the HyperlipidemiasH Buchwald, R L Varco, J R Boen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1979
Management of thoracic outlet syndromeE C McGough, M B Pearce, J P Byrne
JAMA|September 16, 1992
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) GroupH Buchwald, J P Matts, L L Fitch, et al.
The New England Journal of Medicine|October 4, 1990
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)H Buchwald, R L Varco, J P Matts, et al.
Controlled Clinical Trials|April 11, 1991
Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH GroupJ P Matts, H Buchwald, L L Fitch, et al.
Journal of Clinical Epidemiology|March 1, 1995
Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarctionJ P Matts, H Buchwald, L L Fitch, et al.
Surgery|October 1, 1982
The Program on the Surgical Control of the Hyperlipidemias: a status reportH Buchwald, R B Moore, J P Matts, et al.
Clinical and Vaccine Immunology : CVI|September 8, 2012
Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humansJ E Ledgerwood, Z Hu, I J Gordon, et al.
Archives of Internal Medicine|June 13, 1998
Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the HyperlipidemiasH Buchwald, R L Varco, J R Boen, et al.
Pageof 1